Marex Group plc Ordinary Shares
NASDAQ:MRXFinancial - Capital Markets
+$0.93 today
- Market cap
- $4.61B
- Beta
- -0.00
- P/E (TTM)
- 14.5
- EPS (TTM)
- $4.32
- Dividend yield
- 0.98%
Volume 0.83M
Average 1.11M
MRX Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Marex Group plc Ordinary SharesNASDAQ: MRX
Cost of Revenue · Q2 FY2026 · quarter ended Jun 2026
Cost of revenue remains negative
Q2 FY2026 cost of revenue was $0, compared with $305.9M a year earlier. Over 3 fiscal years it compounded at +43.1% a year.
Context
- Cost of revenue amounted to 25.3% of revenue in FY2025, down 30.3 pp from a year earlier.
- Cost of revenue increased in 2 of the last 3 fiscal years.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 917.7M USD
- Year-over-year change
- -42.9%
- 4-year CAGR
- +10.8%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 917.7M | -42.9% |
| FY2024 | 2024-12-31 | 1.61B | +143.8% |
| FY2023 | 2023-12-31 | 659.4M | +110.7% |
| FY2022 | 2022-12-31 | 313M | -48.6% |
| FY2021 | 2021-12-31 | 609.5M | — |
Cost of Revenue vs competitors
How MRX compares with its peers on the latest reported figures
- MRX's FY2025 cost of revenue of $917.7M is the 7th highest of the 10 companies compared; the peer median is $2.93B.
- Its year-over-year change of -42.9% is the 9th highest of 10, against a peer median of -12.0%.
- Cost of revenue amounts to 25.3% of revenue for MRX, versus a peer median of 31.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $153.58B | +19.5% | +25.8% | 97.4% | |
| LTM Sep 2026 | $52.45B | -24.9% | +39.8% | 42.5% | |
| LTM Sep 2026 | $51.09B | +5.8% | +57.9% | 39.4% | |
| LTM Sep 2026 | $3.36B | -30.1% | +3.3% | 36.8% | |
| LTM Aug 2026 | $2.93B | -32.8% | +8.9% | 23.5% | |
| LTM Sep 2026 | $973.79M | +8.9% | +53.3% | 14.6% | |
MRXMarex Group plc Ordinary Shares | FY2025 | $917.7M | -42.9% | +43.1% | 25.3% |
| LTM Jun 2026 | $702.89M | +6.7% | +15.8% | 31.9% | |
| LTM Sep 2026 | $267.36M | -82.8% | -30.5% | 7.7% | |
| LTM Sep 2026 | $221.55M | -12.0% | +8.7% | 25.5% | |
| Peer median (excluding MRX) | $2.93B | -12.0% | +15.8% | 31.9% | |
Competitors are the stored peer set for MRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 851.7M | 1.18B | 2.35B | 2.89B | 3.63B |
| Cost of Revenue | 609.5M | 313M | 659.4M | 1.61B | 917.7M |
| Gross Profit | 825.3M | 862.3M | 1.69B | 1.29B | 2.71B |
| Gross Margin | 96.9% | 73.4% | 72.0% | 44.5% | 74.7% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 82.5M | 120.1M | 798.8M | 247.1M | 0 |
| Operating Expenses | 144.8M | 223.1M | 798.8M | 450.9M | 1.55B |
| Depreciation & Amortization | 10.3M | 13.8M | 21.9M | 28.8M | 36.1M |
| EBITDA | 106.6M | 284.3M | 705.4M | 865.8M | 1.21B |
| EBITDA Margin | 12.5% | 24.2% | 30.0% | 29.9% | 33.3% |
| Operating Income | 68.6M | 270.5M | 683.5M | 836.3M | 1.16B |
| Operating Margin | 8.1% | 23.0% | 29.1% | 28.9% | 32.0% |
| Interest Income | 23.1M | 0 | (5.4M) | (8.7M) | 912.8M |
| Interest Expense | 26.4M | 165M | 470.2M | 538.1M | 760.2M |
| Other Income / Expenses | 1.3M | (148.9M) | (487M) | (540.5M) | (749.2M) |
| Income Before Tax | 69.9M | 121.6M | 196.5M | 295.8M | 411.6M |
| Pre-Tax Margin | 8.2% | 10.3% | 8.4% | 10.2% | 11.3% |
| Income Tax Expense | 13.4M | 23.4M | 55.2M | 77.8M | 103.7M |
| Net Income | 56.5M | 91.6M | 128M | 218M | 308.2M |
| Net Margin | 6.6% | 7.8% | 5.4% | 7.5% | 8.5% |
| EPS (Basic) | 0.80 | 1.29 | 1.94 | 2.96 | 4.13 |
| EPS (Diluted) | 0.80 | 1.36 | 1.82 | 2.72 | 3.87 |
| Weighted Avg Shares | 70.82M | 70.82M | 72.22M | 80.15M | 71.35M |
| Weighted Avg Shares (Diluted) | 70.82M | 70.82M | 72.22M | 75.28M | 76.13M |
Marex Group plc Ordinary Shares
NASDAQ:MRX
Intrinsic Alpha fair value
Locked
Current Price
$64.10
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.